SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : JBII - The Secret Catalyst Turns Plastics into Oil

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Rawnoc10/13/2012 8:29:11 PM
1 Recommendation   of 704
 
Both Sanofi (SNY) and Merck (MRK) have put in first-round offers for diabetes drug maker Amylin Pharmaceuticals (AMLN), according to sources close to the private negotiations.
http://blogs.barrons.com/stockstowatchtoday/2012/05/25/reports-sanofi-merck-bid-at-least-25-per-share-for-amylin/?mod=yahoobarrons

AMLN since bought out. Any prosecution of the "sources close to the private negotiations" for exercising their 1st amendment rights?

lol

"...in the United States, generally publishing classified information is not a crime. The sort of information that a news organization can be prosecuted for publishing is limited to: nuclear secrets (Atomic Energy Act), the identities of covert agents (Intelligence Identities Protection Act), and certain forms of communications intelligence (Section 798 of the Espionage Act)."
gigaom.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext